Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome
Status:
Terminated
Trial end date:
2020-04-29
Target enrollment:
Participant gender:
Summary
This is a Group Sequential Test multicenter, randomized, double blind, placebo controlled
phase II proof of concept trial with parallel groups to evaluate the efficacy and the safety
of BP1.4979 15mg BID compared to placebo in RLS patients during 2 weeks double blind
treatment.